Neshat Masud
Neshat Masud
Androgen receptor (AR) signaling have been frequently targeted for treating prostate cancer (PCa). Even though primarily patients receive a good therapeutic outcome by targeting AR signaling axis, eventually it emerges resistance by alterin...
Hai Zhou,Dantong Sun,Junyan Tao et al.
Hai Zhou et al.
YES proto-oncogene 1 (YES1) is an SRC family kinase (SFK) that plays a key role in cancer cell proliferation, adhesion, invasion, survival, and angiogenesis during tumorigenesis and tumor development. Reports suggest that YES1 amplification...
Particle implantation combined with chemotherapy for rhabdomyosarcoma of the head and neck: A 8-year long-term follow-up case report [0.03%]
头颈部横纹肌肉瘤粒子植入联合化疗长期随访病例报道
Sidou He,Shuhang Tian,Na Xu et al.
Sidou He et al.
Rhabdomyosarcomas (RMSs) are highly malignant soft-tissue sarcomas. Head and neck RMSs often pose unique challenges to treatment because of their closeness to important structures. We here report a rare case of a 1-year-old boy with a 1-mon...
Case Reports
Cancer innovation. 2023 Apr 20;2(3):233-236. DOI:10.1002/cai2.71 2023
A bibliometric analysis of worldwide cancer research using machine learning methods [0.03%]
基于机器学习方法的全球癌症研究文献计量分析
Lianghong Lin,Likeng Liang,Maojie Wang et al.
Lianghong Lin et al.
With the progress and development of computer technology, applying machine learning methods to cancer research has become an important research field. To analyze the most recent research status and trends, main research topics, topic evolut...
Third-line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double-blind phase 2 study [0.03%]
一项III期及以上ALTER1202研究的探索性分析：安罗替尼治疗复发或难治小细胞肺癌脑转移患者的疗效和安全性：一项随机、双盲II期临床试验
Ying Cheng,Qiming Wang,Kai Li et al.
Ying Cheng et al.
Background: The prognosis of patients with small cell lung cancer (SCLC) and brain metastases (BM) was poor. This study aimed to explore the efficacy and safety of anlotinib as third-line or above treatment in SCLC with B...
Flexible bioelectronic innovation for personalized health management [0.03%]
面向个性化健康管理的柔性生物电子创新技术研究与发展
Maowen Xie,Guang Yao,Yuan Lin
Maowen Xie
With the vigorous development of intelligent medical care and interdisciplinary science, innovative flexible bioelectronics (FBEs) are emerging in health monitoring, disease diagnosis and treatment, and even cancer therapy. This work commen...
A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer [0.03%]
免疫检查点抑制剂治疗三阴性乳腺癌晚期患者的真实世界研究
Zheng Zhang,Yadi Zhang,Chuanling Liu et al.
Zheng Zhang et al.
Background: Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Immune checkpoint inhibitors (ICIs) have been widely used to treat various tumors and have changed the landscape of tumor mana...
Haili Qian,Adriana Sujey Beltran
Haili Qian
Mesoscale characteristics and their interdimensional correlation are the focus of contemporary interdisciplinary research. Mesoscience is a discipline that has the potential to radically update the existing knowledge structure, which differ...
Kang Miao,Li Zhang,Xiaoyan Si
Kang Miao
Pyrotinib is a novel human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor (TKI). Previous studies of pyrotinib showed that it is mainly excreted through the gastrointestinal tract rather than the kidneys, with little ef...
Case Reports
Cancer innovation. 2022 Dec 4;1(4):344-347. DOI:10.1002/cai2.38 2022